Poster

• Azeem, Waqas; Lellahi, Seyed Mohammad; Hua, Yaping et al. (2025). Early IDO-1 expression in activated DCs and the positive feedback response to IDO-1 Inhibitors. (ekstern lenke)
• Azeem, Waqas; Lellahi, Seyed Mohammad; Hua, Yaping et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy.. (ekstern lenke)
• Hua, Yaping; Xing, Yuan; Shen, Yunheng et al. (2024). Potential of propionyl cinobufagin for the treatment of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC). (ekstern lenke)
• Azeem, Waqas; Lellahi, Seyed Mohammad; Hua, Yaping et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy. (ekstern lenke)
• Azeem, Waqas; Lellahi, Mohammad; Hua, Yaping et al. (2023). IDO-1 regulation in human dendritic cells. (ekstern lenke)
• Hua, Yaping; Xing, Yuan; Shen, Yunheng et al. (2023). Potential of propionyl cinobufagin for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and neuroendocrine prostate cancer (NEPC). (ekstern lenke)
• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (ekstern lenke)
• Azeem, Waqas; Lellahi, Seyed Mohammad; Hua, Yaping et al. (2023). Regulation of Indoleamine dioxygenase 1 in human dendritic cells. (ekstern lenke)
• Hua, Yaping; Xing, Yuan; Shen, Yunheng et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (ekstern lenke)
• Lellahi, Seyed Mohammad; Azeem, Waqas; Hua, Yaping et al. (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function. (ekstern lenke)
• Azeem, Waqas; Lellahi, Seyed Mohammad; Hua, Yaping et al. (2022). Robust and potent dendritic cells for cancer immunotherapy. (ekstern lenke)
• Hua, Yaping; Xing, Yuan; Shen, Yunheng et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (ekstern lenke)
• Azeem, Waqas; Lellahi, Mohammad; Hua, Yaping et al. (2022). Robust production of potent dendritic cells for cancer immunotherapy. (ekstern lenke)
• Hua, Yaping; Xing, Yuan; Shen, Yunheng et al. (2020). Novel STAT3 inhibitors targeting STAT3 dimerization by binding to STAT3 SH2 domain.. (ekstern lenke)

Vitenskapelig artikkel

• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Gjertsen, Bjørn Tore et al. (2023). A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.. (ekstern lenke)
• Lellahi, Seyed Mohammad; Azeem, Waqas; Hua, Yaping et al. (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. (ekstern lenke)
• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. (ekstern lenke)
• Hua, Yaping; Yuan, Xing; Shen, Yun-Heng et al. (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. (ekstern lenke)
• Azeem, Waqas; Olsen, Jan Roger; Hellem, Margrete Reime et al. (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. (ekstern lenke)
• Azeem, Waqas; Bakke, Ragnhild Maukon; Gabriel, Benjamin et al. (2021). Evaluation of β-catenin inhibition of axitinib and nitazoxanide in human monocyte-derived dendritic cells. (ekstern lenke)
• Azeem, Waqas; Bakke, Ragnhild Maukon; Appel, Silke et al. (2020). Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. (ekstern lenke)
• Hua, Yaping; Azeem, Waqas; Shen, Yunheng et al. (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. (ekstern lenke)
• Azeem, Waqas; Hellem, Margrete Reime; Olsen, Jan Roger et al. (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. (ekstern lenke)
• Olsen, Jan Roger; Azeem, Waqas; Hellem, Margrete Reime et al. (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. (ekstern lenke)
• Sprater, Florian; Azeem, Waqas; Appel, Silke (2014). Activation of peroxisome proliferator-activated receptor gamma leads to upregulation of ESE-3 expression in human monocyte-derived dendritic cells. (ekstern lenke)

Vitenskapelig foredrag

• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (ekstern lenke)

Faglig kapittel

• Azeem, Waqas; Hua, Yaping; Kalland, Karl Henning et al. (2022). Models of Tumor Progression in Prostate Cancer. (ekstern lenke)

Doktorgradsavhandling

• Azeem, Waqas; Kalland, Karl-Henning; Øyan, Anne Margrete et al. (2018). Regulatory patterns in prostate cell differentiation – investigation of transcription factors AR, GATA2 and NKX3-1. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Azeem, Waqas; Hua, Yaping; Kalland, Karl-Henning et al. (2017). Models of Tumor Progression in Prostate Cancer. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin